RETRACTION: TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation (Retraction of Vol 248, Pg 1527, 2023)

被引：0
|
作者：
Chen, Y.
Ma, J.
Zhang, M.
机构：
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2024年 / 249卷
关键词：
D O I：
10.3389/ebm.2024.10243
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation
    Chen, Yuanjian
    Ma, Jun
    Zhang, Mingming
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 248 (18) : 1527 - 1536
  • [2] RETRACTION: Retraction Note: TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway (Retraction of Vol 38, art no 104, 2019)
    Sun, Juntao
    Zhang, Tianyu
    Cheng, Mengmeng
    Hong, Liwen
    Zhang, Chen
    Xie, Mengfan
    Sun, Peijun
    Fan, Rong
    Wang, Zhengting
    Wang, Lei
    Zhong, Jie
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [3] RETRACTION: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2 (Retraction of Vol 24, Pg 1012, 2021)
    Hong, Sen
    Li, Shiquan
    Bi, Miaomiao
    Yu, Haiyao
    Yan, Zhenkun
    Liu, Tao
    Wang, Helei
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 33 : 208 - 208
  • [4] RETRACTION: LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression (Retraction of Vol 119, Pg 4496, 2018)
    Zhu, Feng
    Zhang, Xinjun
    Yu, Qinnan
    Han, Guangye
    Diao, Fengxia
    Wu, Chunlei
    Zhang, Yan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S15 - S15
  • [5] RETRACTION: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2 (Retraction of Vol 24, Pg 4328, 2020)
    Meng, Q. -Z.
    Cong, C. -H.
    LI, X. -J.
    Zhu, F.
    Zhao, X.
    Chen, F. -W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (14) : 4947 - 4947
  • [6] RETRACTION: EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression (Retraction of Vol 11, Pg 7853, 2018)
    Wang, C.
    Li, X.
    Zhang, J.
    Ge, Z.
    Chen, H.
    Hu, J.
    ONCOTARGETS AND THERAPY, 2023, 16 : 673 - 673
  • [7] Retraction Note: TRIM29 facilitates the epithelial‑to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
    Juntao Sun
    Tianyu Zhang
    Mengmeng Cheng
    Liwen Hong
    Chen Zhang
    Mengfan Xie
    Peijun Sun
    Rong Fan
    Zhengting Wang
    Lei Wang
    Jie Zhong
    Journal of Experimental & Clinical Cancer Research, 41
  • [8] RETRACTION: Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter (Retraction of Vol 8, art no 571297, 2020)
    Lu, Y.
    Hou, K.
    Li, M.
    Wu, X.
    Yuan, S.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [9] RETRACTION: MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2 (Retraction of Vol 23, Pg 8795, 2019)
    Pan, M. -Z.
    Song, Y. -L.
    Gao, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2156 - 2156
  • [10] RETRACTION: APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion (Retraction of Vol 34, Pg 970, 2023)
    Cui, L.
    Zhang, J-Y
    Ren, Z-P
    Zhao, H-J
    Li, G-S
    ANTI-CANCER DRUGS, 2023, 34 (08) : 970 - 970
12345